Verleden S E, Vos R, Vandermeulen E, Ruttens D, Bellon H, Heigl T, Van Raemdonck D E, Verleden G M, Lama V, Ross B D, Galbán C J, Vanaudenaerde B M
Lung Transplant Unit, Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium.
Pneumology Department, University of Michigan, Ann Arbor, MI.
Am J Transplant. 2016 Nov;16(11):3262-3269. doi: 10.1111/ajt.13945. Epub 2016 Jul 29.
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation. Air trapping and mosaic attenuation are typical radiological features of BOS; however, quantitative evaluation remains troublesome. We evaluated parametric response mapping (PRM, voxel-to-voxel comparison of inspiratory and expiratory computed tomography [CT] scans) in lung transplant recipients diagnosed with BOS (n = 20) and time-matched stable lung transplant recipients (n = 20). Serial PRM measurements were performed prediagnosis, at time of BOS diagnosis, and postdiagnosis (T , T , and T , respectively), or at a postoperatively matched time in stable patients. PRM results were correlated with pulmonary function and confirmed by microCT analysis of end-stage explanted lung tissue. Using PRM, we observed an increase in functional small airway disease (fSAD), from T to T (p = 0.006) and a concurrent decrease in healthy parenchyma (p = 0.02) in the BOS group. This change in PRM continued to T , which was significantly different compared to the stable patients (p = 0.0002). At BOS diagnosis, the increase in fSAD was strongly associated with a decrease in forced expiratory volume in 1 s (p = 0.011). Micro-CT confirmed the presence of airway obliteration in a sample of a BOS patient identified with 67% fSAD by PRM. We demonstrated the use of PRM as an adequate output to monitor BOS progression in lung transplant recipients.
闭塞性细支气管炎综合征(BOS)仍是肺移植后的主要并发症。气体潴留和马赛克样衰减是BOS典型的影像学特征;然而,定量评估仍然很困难。我们对20例被诊断为BOS的肺移植受者和20例时间匹配的稳定肺移植受者进行了参数反应映射(PRM,吸气和呼气计算机断层扫描[CT]扫描的体素到体素比较)评估。在诊断前、BOS诊断时和诊断后(分别为T₁、T₂和T₃)或在稳定患者术后匹配时间进行了系列PRM测量。PRM结果与肺功能相关,并通过对终末期移植肺组织的显微CT分析得到证实。使用PRM,我们观察到BOS组中功能性小气道疾病(fSAD)从T₁到T₂增加(p = 0.006),同时健康实质减少(p = 0.02)。PRM的这种变化持续到T₃,与稳定患者相比有显著差异(p = 0.0002)。在BOS诊断时,fSAD的增加与第1秒用力呼气量的减少密切相关(p = 0.011)。显微CT证实了一名通过PRM确定fSAD为67%的BOS患者样本中存在气道闭塞。我们证明了PRM可作为监测肺移植受者BOS进展的合适指标。